癫痫设备市场规模、份额及成长分析（按产品类型、技术平台、最终用户和地区）－2025-2032 年产业预测

2023 年癫痫设备市场规模价值 22 亿美元，预计将从 2024 年的 24.2 亿美元增长到 2032 年的 51.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.0%。

全球癫痫设备市场正呈现显着的成长轨迹，这得益于癫痫盛行率的上升和医疗技术的进步。人们对癫痫神经刺激设备和穿戴式癫痫监测工具，旨在改善癫痫的检测、管理和患者预后。然而，市场扩张面临包括高成本、报销选择有限以及训练有素的专业人员短缺等障碍。目前，北美引领市场，然而，受医疗基础设施加强和癫痫管理意识不断提高的推动，亚太地区正在经历强劲增长。主要趋势包括持续的技术创新和以患者为中心的解决方案，反映了医疗保健提供者和患者不断变化的需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

癫痫设备市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 旧版设备
• 穿戴式装置
• 嵌入式装置
• 饮食疗法

癫痫设备市场规模：技术平台与复合年增长率（2025-2032）

• 市场概览
• 迷走神经刺激
• 深部脑部刺激
• 加速感应器
• 反应性神经刺激疗法

癫痫设备市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 神经内科中心
• 居家照护

癫痫设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic plc（Ireland）
• LivaNova PLC（UK）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Neuropace, Inc.（USA）
• Nihon Kohden Corporation（Japan）
• Natus Medical Incorporated（USA）
• Compumedics Limited（Australia）
• UCB SA（Belgium）
• Sunovion Pharmaceuticals Inc.（USA）
• SK Biopharmaceuticals（South Korea）
• Zogenix, Inc.（USA）
• Takeda Pharmaceutical Company Limited（Japan）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Johnson & Johnson（USA）
• Masimo Corporation（USA）

结论和建议

Epilepsy Devices Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.42 billion in 2024 to USD 5.19 billion by 2032, growing at a CAGR of 10.0% during the forecast period (2025-2032).

The Global Epilepsy Devices Market is on a notable growth trajectory, fueled by the rising prevalence of epilepsy and advancements in medical technology. There is a growing demand for epilepsy devices, including implantable neurostimulators and wearable seizure monitoring tools, which aim to improve seizure detection, management, and patient outcomes. However, market expansion faces hurdles such as high costs, limited reimbursement options, and a shortage of trained professionals. North America currently leads the market, while the Asia-Pacific region is experiencing robust growth, bolstered by enhancements in healthcare infrastructure and increased awareness of epilepsy management. Key trends include continuous technological innovation and a focus on patient-centric solutions, reflecting the evolving needs of both healthcare providers and patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Epilepsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Epilepsy Devices Market Segments Analysis

Global Epilepsy Devices Market is segmented by Product Type, Technology Platform, End User and region. Based on Product Type, the market is segmented into Conventional Devices, Wearable Devices, Implantable Devices and Diet. Based on Technology Platform, the market is segmented into Vagus Nerve Stimulation, Deep Brain Stimulation, Accelerometery and Responsive Neurostimulation. Based on End User, the market is segmented into Hospitals and Clinics, Neurology Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Epilepsy Devices Market

The rising global incidence of epilepsy has significantly expanded the patient population, which in turn has heightened the demand for innovative medical solutions. Recent technological advancements in epilepsy devices, such as implantable neurostimulators and responsive neurostimulation systems, have greatly enhanced seizure control and positively impacted patient outcomes. Additionally, the increasing awareness surrounding epilepsy, coupled with the critical importance of early diagnosis and intervention, has further stimulated market growth. This confluence of factors not only showcases the urgent need for effective treatment options but also highlights the evolving landscape of the epilepsy devices market as it adapts to patients' needs.

Restraints in the Epilepsy Devices Market

A significant constraint within the epilepsy devices market is the high cost of advanced devices, which limits accessibility for a large segment of the population, particularly in regions with inadequate healthcare resources. Furthermore, reimbursement policies and insurance coverage limitations can hinder widespread adoption of these technologies. The requirement for specialized professionals to effectively implement and monitor these devices adds another layer of complexity, emphasizing the need for a robust healthcare infrastructure to support their use. Collectively, these factors contribute to the challenges faced in expanding the market reach of epilepsy devices, restricting their potential impact on patient care.

Market Trends of the Epilepsy Devices Market

The Epilepsy Devices market is witnessing a significant trend towards the adoption of wearable seizure monitoring devices, underscoring a shift towards patient-centric, non-invasive solutions that facilitate continuous monitoring. This growing emphasis on innovative technology is complemented by advancements in responsive neurostimulation, which offers real-time adaptive responses to abnormal brain activity. Moreover, the market is evolving towards personalized treatment approaches, with health care providers increasingly focusing on customizing therapeutic strategies to align with individual patient profiles. These factors highlight a holistic approach to epilepsy management, ultimately driving growth and enhancing the quality of life for those affected by the condition.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Epilepsy Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Conventional Devices
• Wearable Devices
• Implantable Devices
• Diet

Global Epilepsy Devices Market Size by Technology Platform & CAGR (2025-2032)

• Market Overview
• Vagus Nerve Stimulation
• Deep Brain Stimulation
• Accelerometery
• Responsive Neurostimulation

Global Epilepsy Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Neurology Centers
• Home Care Settings

Global Epilepsy Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Technology Platform, End User)
  • US
  • Canada
• Europe (Product Type, Technology Platform, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology Platform, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology Platform, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology Platform, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuropace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A. (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunovion Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Biopharmaceuticals (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zogenix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations